NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosis
Cecilie Ammitzbøll(University of Copenhagen), Finn Sellebjerg(Danish Multiple Sclerosis Center), Henrik Lundell(Hvidovre Hospital), Rikke Ratzer(University of Copenhagen), Per Soelberg Sørensen(University of Copenhagen), Jeppe Romme Christensen(Aarhus University Hospital), Melinda Magyari(University of Copenhagen), Lars Börnsen(University of Copenhagen), Karen Schreiber(Guy's and St Thomas' NHS Foundation Trust), Tim B. Dyrby(Hvidovre Hospital), Pernille Iversen(University of Copenhagen), P. E. H. Jensen(Copenhagen University Hospital), HR Siebner(University of Copenhagen)
Cited by 13
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study
|The Lancet|2001|1.1k
Multiple Sclerosis Severity Score
|Neurology|2005|957